Outcome of the Board meeting held on 9th April, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Indrayani Biotech discussed a preliminary proposal to demerger its food division into a separate company. The Board has approved forming a 'Restructuring Committee' to evaluate this restructuring option, which is authorized to appoint legal counsel, tax advisors, and merchant bankers for professional opinions and feasibility reports. No final decision has been made yet. Separately, the Board appointed M/S VAITHIANATHAN & ASSOCIATES as Internal Auditor for FY 2025-26 and 2026-27. The meeting lasted about 65 minutes.
The demerger is still in early evaluation stage with no concrete timeline or terms announced. Until a formal scheme is filed and approved, shareholders should not expect immediate changes. The appointment of internal auditors indicates continued focus on governance.